Full-Time

Senior Bioinformatics & ML Scientist

Nomic

Nomic

51-200 employees

high-throughput proteomics platform employing nELISA

No salary listed

Remote in USA + 1 more

More locations: Remote in Canada

Remote

Category
Biology & Biotech (2)
,
Required Skills
Python
R
Machine Learning
Data Analysis
Requirements
  • PhD (or equivalent experience in Bioinformatics, Computational Biology, ML, or a related quantitative field.)
  • Direct experience analyzing proteomics and transcriptomics datasets
  • Experience working with data from target discovery, perturbation, or functional genomics workflows.
  • 5+ years of hands-on experience building bioinformatics or ML pipelines in Python and/or R.
  • Comfortable staying hands-on with coding and analysis while mentoring others.
  • Strong statistical and data-wrangling skills, including QC and normalization.
  • Familiarity with reproducibility and collaborative coding practices.
  • Experience collaborating with engineers, scientists, or product teams.
  • Experience contributing to scientific publications or technical content.
  • Experience with customer-facing scientific work is ideal.
  • Understanding of how pharma and biotech teams evaluate biological data is ideal.
  • Excellent written and verbal communication skills.
Responsibilities
  • Build and improve pipelines for proteomic and transcriptomic data: QC, normalization, batch correction, feature engineering, and integration.
  • Develop ML models and analytical methods for target discovery, perturbation and functional genomics analysis, and phenotype classification.
  • Prototype ML-driven approaches and work with engineering teams to productionize them.
  • Interpret multi-omics datasets and connect data patterns to underlying biology.
  • Support analyses involving perturbation screens or functional genomics methods.
  • Define and translate customer analysis needs into specific Portal features and workflows.
  • Support customer projects with exploratory and confirmatory analyses.
  • Identify and communicate the insights most relevant to customer decisions.
  • Present data clearly and rigorously in sharable notebooks, presentations, and discussions.
  • Work with product, commercial, and scientific teams to define high-impact use cases.
  • Contribute to scientific content that strengthens Nomic’s leadership.

Nplex Biosciences develops proteomics tools using nanotechnology, including the nELISA platform for high-throughput protein measurement. The platform uses DNA nanotechnology to identify proteins on micron-sized beads, enabling miniaturized, highly parallel immunoassays. It differentiates itself by combining DNA-based protein identification with bead-based assays and a scalable, cost-efficient workflow that lowers the cost of antibody-based proteomics. Its goal is to provide a reliable, scalable proteomics platform that supports drug discovery, biomarker discovery, and personalized medicine.

Company Size

51-200

Company Stage

Series B

Total Funding

$60.1M

Headquarters

Montreal, Canada

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Omni 1000 democratizes proteome-wide profiling for drug discovery and biomarker validation.[5]
  • $42M Series B September 2024 funds commercial expansion amid rising demand.[5]
  • Context-specific ~300-protein panels enable targeted discovery without multiplexing limitations.[2]

What critics are saying

  • Olink's Explore HT delivers 6000+ proteins, capturing larger pharma budgets.[1]
  • SomaScan's 11,000-protein aptamer technology erodes biomarker discovery market share.[1]
  • Post-Series B cash burn exceeds revenue as manufacturing scales in 2026.[1]

What makes Nomic unique

  • nELISA technology enables 1000-plex protein measurement at $50 per sample affordably.[5]
  • DNA-barcoded beads decode protein identity on standard flow cytometers seamlessly.[3]
  • End-to-end service model compatible with existing lab workflows and automation.[4]

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Nomic who can refer or advise you

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

4%

2 year growth

1%
Yahoo Finance
Sep 19th, 2024
Nomic® Secures $42M in Oversubscribed Series B to Expand Access to Protein Profiling

MONTREAL, September 17, 2024--Nomic Bio ("Nomic"), the Protein Profiling company, today announces the completion of an oversubscribed $42 million Series B funding round. The fresh capital will enable Nomic to accelerate the expansion of its commercial operations, further invest in advancing its state-of-the-art protein profiling platform, and broaden its transformative offerings to meet growing demand.

BetaKit
Mar 18th, 2020
11 Canadian companies in Y Combinator’s Winter 2020 Demo Day

This week, Y Combinator (YC) held its Winter 2020 Demo Day, the 30th for the Silicon Valley incubator. To minimize health concerns during the COVID-19 outbreak, YC opted to host the demo day online. For this cohort, 16 Canadian startups participated.

TechCrunch
Mar 17th, 2020
All the companies from Y Combinator’s W20 Demo Day, Part IV: Healthcare, Biotech, Fintech and Nonprofits

Y Combinator’s Demo Day was a bit different this time around.